Use of an older class of type 2 diabetes drugs called glitazones, also known as thiazolidinediones or TZDs for short, is linked to a 22% reduced risk of dementia, reveals a long term study published in the open access journal BMJ Open Diabetes Research & Care.
with those treated with metformin alone. They drew on the electronic health records of 559,106 people diagnosed with type 2 diabetes from the national Veteran Affairs Health System, spanning the period from January 2000 to December 2019. and given a first prescription of metformin, or a sulfonylurea , or a TZD between January 2001 and December 2017 were included in the study. Their health was tracked for an average of nearly 8 years.
Specifically, it was associated with an 11% lower risk of Alzheimer's disease and a 57% lower risk of vascular dementia. Given that vascular diseases increase the risk of Alzheimer's disease, TZDs may also help to reduce dementia and Alzheimer's disease in part through their favorable effects on the vascular system, say the researchers.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
No plans to change law on cannabis, No 10 saysIt follows reports the home secretary was considering upgrading cannabis to a Class A drug.
続きを読む »
Ujah banned for 22 months after failed drug testBritish sprinter CJ Ujah is banned for 22 months after testing positive for two banned substances at the Tokyo Olympics.
続きを読む »
Patterns of underlying health issues linked to poorer outcomes after fractures in older adultsHaving specific combinations of underlying health issues is a significant risk for poorer health outcomes in older adults who've had a fracture, a new study from the Garvan Institute of Medical Research shows.
続きを読む »
Bangor Care Home: Abusive letters 'not properly investigated'Disturbing anonymous letters aimed at two dementia patients have not been properly investigated, their families claim SpotlightNI SpotlightNI
続きを読む »